The Gordon Research Seminar on Medicinal Chemistry is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this meeting is on building an understanding of foundational principles and strategies that can be applied by medicinal chemists in the pursuit of novel small molecule drugs. Faculty presenters will describe and explain various fundamental medicinal chemistry principles used to generate small molecule leads and optimize their pharmacological, pharmacokinetic, metabolic and toxicological profiles in the pursuit of drug candidates. New concepts and technologies will be presented with examples of successful application to the acceleration of lead generation and drug discovery. This seminar is organized in a workshop format, allowing for close interaction between practicing medicinal chemists and participating attendees. Case studies of drug discovery projects will highlight successful approaches taken to deliver leads, clinical candidates and drugs.
Registration support will be available for participants. Please contact the chair for details.
The seminar will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS, either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The seminar chair will select speakers from abstracts submitted by July 23, 2021. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Information section above.
Gordon Research Seminars are 2-day meetings which take place on the Saturday and Sunday just prior to the start of the associated GRC. The GRS opens with a 1-hour introductory session on Saturday afternoon, followed by a poster session, dinner and a 2-hour session in the evening. Sunday morning begins with breakfast and is followed by another 2-hour session, a second poster session, and lunch. A final 1-hour session takes place just after lunch, and the associated GRC begins later that evening.
An outline of the program components for this GRS is displayed below. The seminar chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by August 23, 2021. Please check back for updates.
Amy Ripka (Lucy Therapeutics, Inc., USA)
Amy Hart (Cormorant Asset Management, USA)
James Barrow (Johns Hopkins/Lieber Institute, USA)
Erin DiMauro (Merck & Co., Inc., USA)
Darby Schmidt (Inzen Therapeutics, USA)
Christopher Brain (Novartis Institutes for Biomedical Research, USA)
- Additional Speakers May Be Selected from Submitted Abstracts
David Price (Vertex, United Kingdom)
Alex Cortez (Bristol Myers Squibb, USA)
Michael Ellis (Bristol-Myers Squibb, USA)
Benjamin Pratt (Pratt Pharma Consulting LLC, USA)
- Additional Discussion Leaders May Be Selected from Submitted Abstracts